Patents by Inventor Taiying Chen

Taiying Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Releasing embedding media from tissue specimens
    Patent number: 6451551
    Abstract: Releasing the embedding medium from an embedded histochemically reactive tissue specimen is provided by contacting the embedded tissue specimen with a releasing composition under conditions sufficient to release a sufficient portion of the embedding medium associated with the histochemically reactive tissue specimen to permit analysis without substantial adverse effect on the histochemical reactivity of the specimen.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: September 17, 2002
    Assignee: BioGenex Laboratories
    Inventors: Guangrong Zhan, Krishan L. Kalra, Sheng-Hui Su, Taiying Chen
  • Method for silver staining a pathologic sample
    Patent number: 6426195
    Abstract: A method of silver staining a pathologic sample is disclosed. The method involves the reduction of silver diamine complexes bound to components of the sample by a reducing agent released from a reducing agent carrier. The use of a reducing agent carrier which slowly releases the reducing agent during the reaction permits staining at ambient temperatures.
    Type: Grant
    Filed: March 28, 2000
    Date of Patent: July 30, 2002
    Inventors: Shude Zhong, Taiying Chen, Sunil Kumar Aggarwal, Sheng-Hui Su
  • Purified mammalian cell binding receptor for bacterial lipopolysaccharide endotoxin and monoclonal antibody
    Patent number: 5045466
    Abstract: The invention is directed to hydridoma cell lines and the monoclonal antibodies produced by the cell lines, where the monoclonal antibodies specifically bind to the lipopolysaccharide endotoxin binding receptor of mammalian cells. Specifically, the monoclonal antibodies binds to a cell receptor which has a molecular mass of 80 kilodaltons, and is specific for the lipid A component of the lipopolysaccharide endotoxin. The monoclonal antibodies are specific for a carbohydrate component of the binding receptor in one instance, and for a protein/peptide receptor in another.
    Type: Grant
    Filed: July 7, 1989
    Date of Patent: September 3, 1991
    Assignee: University of Kansas
    Inventors: David C. Morrison, Taiying Chen, Mei-Guey Lei, Stuart W. Bright, Linda M. Flebbe